Citation:Oberg S, Wenner J, Johansson J, Walther B, Willén R 2005

From Cancer Guidelines Wiki

Citation


Oberg S, Wenner J, Johansson J, Walther B, Willén R. Barrett esophagus: risk factors for progression to dysplasia and adenocarcinoma. Ann Surg 2005 Jul;242(1):49-54 Abstract available at http://www.ncbi.nlm.nih.gov/pubmed/15973101.



Critical appraisals

Critical appraisal linkClinical questionAssigned toStatus
Are there any treatments that prevent progression of BO to cancer?Professor David Watson MBBS, MD, FRACScompleted
What are the risk factors for progression from non-dysplastic BO to high-grade dysplasia or adenocarcinoma?Professor David Whiteman B Med Sci, MBBS (Hons) PhD FAFPHMcompleted
Are there groups of patients with non-dysplastic BO that require more frequent surveillance?Dr Henry Tocompleted
Are there groups of patients with BO that can be discharged from surveillance?Conjoint Associate Professor Philip Craigcompleted

Compare quality appraisals for each clinical question

Cited by

  1. Are there groups of patients with non-dysplastic BO that require more frequent surveillance?
  2. NETs guidelines/Imaging